Shandong Sirui Pharmaceutical is an API manufacturer based in China. It holds 4 active US drug master files and 8 valid CEPs across a filed portfolio of 9 molecules.
| Site | FDA FEI |
|---|---|
| Heze, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Dexamethasone | EDQM, US FDA | 3 |
| Fluticasone Propionate | EDQM, US FDA | 2 |
| Abiraterone | US FDA | 1 |
| Betamethasone | EDQM | 1 |
| Fluticasone Furoate | EDQM | 1 |
| Methylprednisolone | EDQM | 1 |
| Mometasone Furoate | EDQM | 1 |
| Triamcinolone | US FDA | 1 |
| Triamcinolone Acetonide | EDQM | 1 |
Also appears on these molecule pages
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Shandong Sirui Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.